KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Thermo Fisher Scientific (TMO) Share-based Compensation (2016 - 2025)

Historic Share-based Compensation for Thermo Fisher Scientific (TMO) over the last 17 years, with Q3 2025 value amounting to $70.0 million.

  • Thermo Fisher Scientific's Share-based Compensation rose 294.12% to $70.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $305.0 million, marking a year-over-year increase of 777.39%. This contributed to the annual value of $301.0 million for FY2024, which is 827.34% up from last year.
  • Latest data reveals that Thermo Fisher Scientific reported Share-based Compensation of $70.0 million as of Q3 2025, which was up 294.12% from $81.0 million recorded in Q2 2025.
  • In the past 5 years, Thermo Fisher Scientific's Share-based Compensation ranged from a high of $84.0 million in Q2 2024 and a low of $51.0 million during Q2 2021
  • For the 5-year period, Thermo Fisher Scientific's Share-based Compensation averaged around $70.6 million, with its median value being $75.0 million (2022).
  • Its Share-based Compensation has fluctuated over the past 5 years, first soared by 5294.12% in 2022, then tumbled by 1866.67% in 2023.
  • Thermo Fisher Scientific's Share-based Compensation (Quarter) stood at $77.0 million in 2021, then fell by 2.6% to $75.0 million in 2022, then dropped by 18.67% to $61.0 million in 2023, then increased by 29.51% to $79.0 million in 2024, then fell by 11.39% to $70.0 million in 2025.
  • Its last three reported values are $70.0 million in Q3 2025, $81.0 million for Q2 2025, and $75.0 million during Q1 2025.